Bharat Coking Coal IPO Analysis: Subscription Rates & Key Details

On: Wednesday, January 14, 2026 12:34 AM
---Advertisement---

Bharat Coking Coal IPO Analyzed

Bharat Coking Coal’s recent Initial Public Offering (IPO) was a huge success, attracting far more money than the company expected. Over 147 people wanted to buy shares, totaling nearly ₹1.2 trillion in bids. This shows investors really believe in the company’s future.

Key Points

  • Huge investor interest: 147x subscription rate for shares.
  • Institutional investors most enthusiastic: 311x subscription rate.
  • Coal India controls 90% of the company post-IPO.
  • Company valued at ₹10,711 crore at the high end.
  • ₹273 crore raised from anchor investors before the offering.
  • First mainboard IPO of 2026, alongside other recent offerings.

Bharat Coking Coal Details

The IPO was a special type called an “offer-for-sale,” meaning Coal India, the parent company, was selling all the shares. This means Coal India will still own almost 90% of Bharat Coking Coal after the IPO. The company makes coking coal, which is used to make steel, and other types of coal.

During the last six months, Bharat Coking Coal made a profit of ₹124 crore with sales of ₹5,659 crore. They also raised extra money before the IPO by selling shares to special investors called “anchor investors” – this brought in over ₹273 crore.

Amagi Media Labs IPO

Meanwhile, another company, Amagi Media Labs, which provides software online, also went public. On its first day, only 6% of the shares were subscribed. Retail investors (ordinary people who buy shares) were the biggest group interested, taking up 28% of the shares.

Amagi Media Labs got money from big investment funds like SBI, ICICI, and HDFC before the IPO, raising around ₹805 crore. The IPO will finish on January 16th, and shares could be worth over ₹7,800 crore if priced at the highest amount.

Biocon QIP

Biocon, a pharmaceutical company, also raised money by selling shares to big investment funds. SBI and ICICI Funds bid for half of the shares offered in this deal, which was for ₹41,500 crore. Biocon is selling shares to institutional investors at a price of ₹368.35 to ₹371.80 per share.

Investing in these companies demonstrates a strong belief in the growing demand for energy and software solutions.